Double dose extracorporeal shockwave may be more effective for …
Oct 8, 2024 · 1. Double-dose ESWT to the gastrocnemius and soleus showed greater improvements in post-stroke ankle plantar flexor spasticity Evidence Rating Level: 1 …
Pomalidomide effective in reducing epistaxis in hereditary …
Oct 11, 2024 · 1. Among patients with hereditary hemorrhagic telangiectasia (HHT), pomalidomide significantly reduced the severity of epistaxis and improved quality of life. 2. …
Semaglutide reduces heart failure events in patients with …
Sep 24, 2024 · 1. Patients in the semaglutide group reported fewer heart failure events than those in the placebo group. 2. No significant difference was observed between groups for …
Landmark Trials & Summaries: The Classics in Medicine - 2 Minute …
A deep understanding of these trials is paramount for every physician, healthcare professional, and trainee, as it lays the foundation for evidence-based clinical decisions made daily. 2MM+ …
Patient Basics: Epiglottitis - 2 Minute Medicine
Nov 30, 2014 · Epiglottitis is a rare, but potentially life-threatening infection. It causes sudden swelling of the epiglottis, which often worsens rapidly, sometimes within hours. Without timely …
Body roundness index may help estimate cardiovascular disease
Oct 5, 2024 · 1. A higher body roundness index (BRI) trajectory is associated with an increased risk of cardiovascular disease (CVD). Evidence Rating Level: 2 (Good) The BRI, first proposed …
The Ultimate Guide to Achieving a Competitive MCAT Score for …
Nov 28, 2023 · Welcome to the ultimate guide that will help you achieve a competitive MCAT score for your medical school admissions. The MCAT (Medical College Admission Test) is a …
Weekly insulin efsitora alfa is non-inferior to daily insulin degludec ...
Oct 9, 2024 · In-depth [randomized-controlled trial]: Between Aug 12, 2022, and May 7, 2024, 893 patients were assessed for eligibility across 82 centers in 6 countries. Included were patients ≥ …
Tirzepatide reduces obstructive sleep apnea symptoms and …
Oct 10, 2024 · 1. In this randomized controlled trial, in patients with both moderate-severe obstructive sleep apnea (OSA) and obesity, it was found that tirzepatide treatment reduced the …
Endeavor BioMedicinesENV-101 (Taladegib): A Safe and Efficacious ...
Jun 12, 2024 · ENV-101 is a safe and well-tolerated, unique, disease-modifying agent in the treatment of IPF. ENV-101 not only improved lung function but also reversed signs of fibrosis …